Retraction notice to "Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer" [International Journal of Biological Macromolecules 245 (2023) 125510]

Int J Biol Macromol. 2025 Jan 3:293:138914. doi: 10.1016/j.ijbiomac.2024.138914. Online ahead of print.
No abstract available

Publication types

  • Retraction of Publication